NPPA Slaps GSK Pharma with Rs 3.54 Crore Demand Over Alleged Drug Overcharging Parthika Patel5 July 2026 1:00 PM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) has informed the stock exchanges that it has received a demand notice from the...
UPSC Invites Pharmacy, Medical Graduates for 186 CDSCO Drug Inspector Posts Parthika Patel5 July 2026 12:30 PM ISTNew Delhi: The Union Public Service Commission (UPSC) has invited online applications for the recruitment of 186 Drug Inspector posts in the Central...
Alkem Labs Gets Appellate Relief in Rs 660.77 Crore Income Tax Dispute Parthika Patel4 July 2026 11:08 PM ISTNew Delhi: Alkem Laboratories Limited has informed the stock exchanges that it has received favourable Orders-in-Appeal from the Commissioner of...
Cipla's Seroflo Rotacaps Under Scanner as Nepal Seizes Suspected Counterfeit Stocks Parthika Patel4 July 2026 10:59 PM ISTNew Delhi: Nepal's Department of Drug Administration (DDA) has launched a nationwide crackdown on suspected counterfeit asthma medicines, seizing...
Aurobindo Pharma Acquires 26% Stake in Solar Firm, Executes Captive Power Agreement Parthika Patel4 July 2026 10:54 PM ISTNew Delhi: Aurobindo Pharma Limited has completed the execution of a solar power purchase agreement with Swarnaakshu Solar Power Private Limited and...
Zydus Inks MoU with Apollo Hospitals to Launch Multi-Cancer Blood Test in India MD Bureau4 July 2026 10:38 PM ISTNew Delhi: Zydus Lifesciences Ltd. has entered into an exclusive agreement with precision oncology company Guardant Health to introduce the Shield...
No Plan to Privatise Haffkine Bio-Pharmaceutical, Maharashtra Govt Clarifies MD Bureau4 July 2026 10:04 PM ISTMumbai: The Maharashtra government on Friday said it has no plan to privatise the state-owned Haffkine Bio-Pharmaceutical Corporation Ltd. and that an...
Aurobindo Pharma Transfers Domestic Branded Generics Business to Wholly Owned Arm Auropharm Parthika Patel3 July 2026 11:43 PM ISTNew Delhi: Aurobindo Pharma Limited has completed the transfer of its domestic branded generic pharmaceutical formulations products business to...
Lupin Receives USFDA EIR for New Jersey Plant with VAI Classification sheeba farhat3 July 2026 11:39 PM ISTMumbai: Global pharma major Lupin Limited (Lupin) has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Syngene Names Former Biocon CEO Siddharth Mittal as Managing Director and CEO sheeba farhat3 July 2026 11:32 PM ISTNew Delhi: Syngene International Limited has announced the appointment of Siddharth Mittal as its Managing Director and Chief Executive Officer (MD...
AstraZeneca Signs USD 1.77 Billion Pact with CSPC to Develop Kidney Disease Therapies sheeba farhat3 July 2026 11:26 PM ISTShanghai: AstraZeneca has entered into a deal worth up to USD 1.77 billion with CSPC Pharmaceutical Group to discover and develop experimental...
DCGI Clears Glenmark's Phase 3 Trial of HER2-Targeted Ovarian Cancer Therapy in India sheeba farhat3 July 2026 11:21 PM ISTNew Delhi: Glenmark Specialty S.A., a wholly owned subsidiary of Glenmark Pharmaceuticals Limited, has advanced its multi-country Phase 3 clinical...
